Skip to content

Guided Imagery & Music in Cancer

Guided Imagery & Music in Active Treatment for Gynecologic or Breast Cancer: An RCT Pilot

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03936075
Enrollment
20
Registered
2019-05-03
Start date
2018-07-01
Completion date
2020-12-31
Last updated
2020-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Breast, Cancer, Metastatic, Cancer Ovaries, Cancer Uterus Cervix

Keywords

receptive music therapy, Guided Imagery & Music (GIM), chemotherapy, radiotherapy, breast cancer, gynecologic cancer

Brief summary

This is an RCT pilot study to explore the potential effects of the Guided Imagery & Music method for women with breast or gynecologic cancer, during active treatment. The study explores the potential impact in quality of life parameters such as mood, fatigue, and hope.

Detailed description

Guided Imagery and Music is a music-assisted psychotherapy method which has been used as a complementary, supportive psychosocial therapy in cancer care. However, its effects have never been explored during the period of active chemotherapy or radiotherapy treatment in various cancer populations, and especially gynecologic and breast cancer. This pilot study is an effort to explore the feasibility of the method to increase quality of life in this population by possibly reducing side-effects of treatment such as fatigue, improving mood, and building resilience as expressed through levels of hope.

Interventions

BEHAVIORALthe Guided Imagery and Music method

the method involves listening to the music while describing the experience to the therapist, any visual imagery that is evoked by the music, emotions, body sensations, thoughts or memories. after the music listening session, there is discussion upon making meaning of the experience and finding resources as potential coping skills

BEHAVIORALstandard care and verbal counselling

the participants receive their usual cancer treatment and two individual counselling sessions

Sponsors

Aretaieion University Hospital
CollaboratorOTHER
SONORA Organisation for Music Therapy and Research
CollaboratorUNKNOWN
Aalborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Intervention model description

two randomised groups, one intervention group and one placebo group

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Speaking Greek * receiving chemotherapy or radiotherapy treatment for breast or gynecologic cancer * first occurrence or metastatic * have an interest in engaging in creative psychotherapies through music

Exclusion criteria

* women with active psychosis or PTSD symptomatology * women receiving other psychological support * women too ill to participate according to doctors' instructions

Design outcomes

Primary

MeasureTime frameDescription
Profiles of Mood States (POMS) Brief version (adapted)Baseline and up to 12 weeks (post-intervention)Brief version adapted in Greek. A 30-item scale designed to assess six different moods namely tension, anger, vigor, fatigue, depression, confusion. It requires to indicate mood state over the last week, with a single word, each item ranging from 0(not at all) to 4 (extremely). The questionnaire is a sum of its 6 sub scales (each addressing the aforementioned moods), with a total score from 0 to 120. Lower scores indicate better mood states.

Secondary

MeasureTime frameDescription
Herth Hope IndexBaseline and up to 12 weeks (post-intervention)A 12-item Likert-format instrument assessing current levels of hope from 1(strongly disagree) to 4 (strongly agree). It consists of three sub scales, examining interconnectedness, temporality and spirituality, and positiveness or expectancy. A higher score of the sum or the 3 sub scales indicates a higher hope level with scores ranging from 12 to 48.
Cancer-related Fatigue Scale (CFS)Baseline and up to 12 weeks (post-intervention)An instrument consisting of 15 items that assess physical, affective, and cognitive dimensions of fatigue at present moment, with Likert scales ranging from 1 to 5. the physical sub scale consists of 7 items, the affective sub scale consists of 4 items, and the cognitive sub scale consists of 3 items and the total of all 3 sub scales indicate that greater scores correspond to greater fatigue levels.
Visual Analogue Scale for Hope (VAS-H)obtained 6 times throughout the completion of intervention (up to 12 weeks)VAS is a single, frequent measurement to address the current levels of hope. Its s based on a 100cm horizontal line from 1cm (hopeless) to 100cm (hopeful)
Visual Analogue Scale for Fatigue (VAS-F)Obtained 6 times throughout the completion of intervention (up to 12 weeks)VAS is a single, frequent measurement to address the current levels of fatigue.

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026